https://www.selleckchem.com/pr....oducts/17-AAG(Geldan
should examine how patient preferences, provider implicit bias, and shared decision-making contribute to these early treatment differences. High serum alkaline phosphatase (ALP) levels are associated with excess all-cause and cardiovascular mortality in patients undergoing hemodialysis (HD). However, the long-term relationship between serum ALP levels and infection-related mortality remains unclear. A total of 3502 maintenance HD patients were registered in the Q-Cohort Study, an observational cohort study in Japan. The pri
Like
Comment
Share
